BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 24672028)

  • 1. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q; He M; Zhou F; Ye F; Gao SJ
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role of SIRT1 in gammaherpesvirus latency and replication.
    He M; Gao SJ
    Cell Cycle; 2014; 13(21):3328-30. PubMed ID: 25485577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.
    Wood JJ; Boyne JR; Paulus C; Jackson BR; Nevels MM; Whitehouse A; Hughes DJ
    J Virol; 2016 Oct; 90(20):9543-55. PubMed ID: 27512077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation.
    Shin HJ; DeCotiis J; Giron M; Palmeri D; Lukac DM
    J Virol; 2014 Jan; 88(2):1281-92. PubMed ID: 24227836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1.
    Dyson OF; Walker LR; Whitehouse A; Cook PP; Akula SM
    PLoS One; 2012; 7(3):e33364. PubMed ID: 22428032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway.
    Li S; Hu H; He Z; Liang D; Sun R; Lan K
    PLoS Pathog; 2016 Oct; 12(10):e1005900. PubMed ID: 27760204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin remodeling controls Kaposi's sarcoma-associated herpesvirus reactivation from latency.
    Hopcraft SE; Pattenden SG; James LI; Frye S; Dittmer DP; Damania B
    PLoS Pathog; 2018 Sep; 14(9):e1007267. PubMed ID: 30212584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.
    Roy A; Dutta D; Iqbal J; Pisano G; Gjyshi O; Ansari MA; Kumar B; Chandran B
    J Virol; 2016 Oct; 90(19):8822-41. PubMed ID: 27466416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
    Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
    J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kruppel-associated box domain-associated protein-1 as a latency regulator for Kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase.
    Chang PC; Fitzgerald LD; Van Geelen A; Izumiya Y; Ellison TJ; Wang DH; Ann DK; Luciw PA; Kung HJ
    Cancer Res; 2009 Jul; 69(14):5681-9. PubMed ID: 19584288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.
    Curreli F; Cerimele F; Muralidhar S; Rosenthal LJ; Cesarman E; Friedman-Kien AE; Flore O
    J Virol; 2002 May; 76(10):5208-19. PubMed ID: 11967335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylation changes at lysine 5 of histone H4 associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus.
    Hwang LR; Cha S; Jong JE; Jang JH; Seo T
    Acta Virol; 2014; 58(3):282-6. PubMed ID: 25283865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
    Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
    J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA.
    Chang M; Brown HJ; Collado-Hidalgo A; Arevalo JM; Galic Z; Symensma TL; Tanaka L; Deng H; Zack JA; Sun R; Cole SW
    J Virol; 2005 Nov; 79(21):13538-47. PubMed ID: 16227274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
    Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
    J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic analysis of KSHV latent and lytic genomes.
    Toth Z; Maglinte DT; Lee SH; Lee HR; Wong LY; Brulois KF; Lee S; Buckley JD; Laird PW; Marquez VE; Jung JU
    PLoS Pathog; 2010 Jul; 6(7):e1001013. PubMed ID: 20661424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.